Sign In
Free Newsletter
New Jersey builds on legacy of leadership in life sciences
New Jersey's life sciences industry tops 127,000 workers as a new report highlights biotech growth, manufacturing and innovation.
Novartis reports progress on $23B US manufacturing expansion
Novartis advances its $23B U.S. manufacturing plan, expanding R&D and drug production as it aims to produce key medicines domestically.
Cellares to manufacture Cabaletta CAR-T under 10-year deal
The 10-year deal will enable automated, large-scale production for autoimmune diseases with Cabaletta Bio's rese-cel therapy.
Cambrex advances $120M API plant expansion in Iowa
Cambrex advances its $120M expansion in Charles City, Iowa, boosting API manufacturing capacity and support complex pharmaceutical production.
Johnson & Johnson invests $1B in Pennsylvania cell therapy facility
The New Brunswick-based health care giant will build a next-generation cell therapy manufacturing facility in the Keystone State's Montgomery County, supported by $41.5 million from the state.
Novartis advances $23B US manufacturing plan in Florida
The new, $70 million radioligand therapy facility is part of the company's $23 billion plan to expand domestic drug production.
Johnson & Johnson cuts drug prices in White House deal
Johnson & Johnson struck a White House deal to lower drug prices under Trump’s pricing policy, gaining relief from U.S. pharma tariffs.
Hovione invests $100M to expand East Windsor manufacturing
The move from the CDMO boosts its end-to-end pharmaceutical manufacturing in the state as well as doubles its U.S. spray-drying capacity.
Cambrex to invest $120M to expand U.S. drug production
The East Rutherford-based CDMO will boost capacity at the nation's largest independent API manufacturing site and add jobs in Iowa amid reshoring efforts.
Merck to build $3B manufacturing facility in Virginia
The Rahway-headquartered company said the 400,000-square-foot center is expected to create 500 jobs and will strengthen nation's life sciences sector.
Celltrion pays $330M for Eli Lilly plant to avoid tariffs, boost output
The play will expand the Korean biopharma's U.S. production, while strengthening New Jersey's life sciences footprint – particularly in Somerset County.
Johnson & Johnson invests $2B in another North Carolina factory
Part of its planned $55 billion U.S. manufacturing expansion, the new biologics factory is the second Tar Heel State site the New Brunswick-based health care giant announced this year.
